Anatara animal health asset update
BRISBANE & MELBOURNE, 28 June, 2019
Highlights
- Anatara provides an update on strategic evaluation of its lead animal health product, Detach®
- Discussions in progress with Australian contract manufacturer, and with potential veterinary sales, marketing and distribution partners to investigate sale of Detach® in Australia
- Review underway of global regulatory environment for Detach® to determine fastest path to market in other jurisdictions
- Research commenced around potential applications for Detach® in areas outside of piglets
- Prior discussions with multi-national animal health companies being further evaluated for product licensing opportunities
Anatara Lifesciences provides an update on the strategic evaluation of Detach®, its non-antibiotic animal health asset which aids in the control of diarrhoeal disease in piglets (known as scour) with potential application in other livestock animals, aquaculture and companion animals.
Please click here to view the ASX announcement. |
